Produktname:(2-Acetyl-4-methylpentyl)trimethylammonium Iodide

IUPAC Name:trimethyl[2-(2-methylpropyl)-3-oxobutyl]azanium iodide

CAS:1069-62-1
Molekulare Formel:C11H24INO
Reinheit:95%+
Katalognummer:CM414743
Molekulargewicht:313.22

Packungseinheit Verfügbarer Vorrat Preis($) Menge
CM414743-1g in stock Ǥʼn
CM414743-5g in stock ƥǵŹ

Nur für den Einsatz in Forschung und Entwicklung..

Anfrage-Formular

   refresh    

Produkt-Details

CAS-Nr.:1069-62-1
Molekulare Formel:C11H24INO
Schmelzpunkt:-
SMILES-Code:[I-].CC(C)CC(C[N+](C)(C)C)C(C)=O
Dichte:
Katalognummer:CM414743
Molekulargewicht:313.22
Siedepunkt:
Mdl-Nr.:MFCD28143141
Lagerung:

Column Infos

Valbenazine
Neurocrine Biosciences announced interim results from the ongoing open-label KINECT®-HD2 study about INGREZZA® (Valbenazine) capsules when used for the long-term treatment of adults with chorea associated with Huntington's disease (HD). Interim data suggest one-capsule, once-daily INGREZZA improved chorea at the first evaluation at Week 2 with sustained efficacy through Week 50. INGREZZA® (Valbenazine) is the only one-capsule, once-daily selective vesicular monoamine transporter 2 (VMAT2) inhibitor approved by FDA for the treatment of adults with tardive dyskinesia and the treatment of chorea associated with Huntington's disease (HD).
Chemenu has been working to develop more compounds for drug discovery. Here are the building blocks we can provide.

Related Products